Science & Technology
Long-Acting Antiviral Implant for the Treatment of Hcv
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N93024C00028
Award Ceiling
$300K
Award Floor
$300K
Close Date
N/A
Total Funding
$300K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N93024C00028
Description
SBIR Phase Phase I award: "LONG-ACTING ANTIVIRAL IMPLANT FOR THE TREATMENT OF HCV" awarded to LUNA LABS USA LLC in Charlottesville, Virginia. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $299,997. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.